Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Gagelmann N, Badbaran A, Salit RB, Schroeder T, et al. Blood 2023 Mar 20:blood.2023019630. doi: 10.1182/blood.2023019630.

Read + Share

Amedeo Smart

Independent Medical Education

Gagelmann N, Badbaran A, Salit RB, Schroeder T, et al. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood 2023 Mar 20:blood.2023019630. doi: 10.1182/blood.2023019630.
PMID: 36940410